Author: Mary Morris, MD, ABIM
When my father, Dr. David Morris, began offering sublingual immunotherapy (SLIT) more than four decades ago, his motivation was to offer patients who were not having success with allergy injection immunotherapy another disease-modifying option. Initially, the patients who gravitated to SLIT were mold-allergic patients who were not helped by or […]
More »
